Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,959 | -16,739 | -10,684 | -3,676 | -50,220 |
| Depreciation Amortization | -65 | -149 | -16 | -2 | 90 |
| Accounts receivable | 228 | 219 | -38 | 141 | 270 |
| Other Working Capital | -1,064 | 27 | -2,182 | -2,136 | -3,390 |
| Other Operating Activity | -3,150 | -4,237 | -2,260 | -3,175 | 19,410 |
| Operating Cash Flow | $-29,010 | $-20,879 | $-15,180 | $-8,848 | $-33,840 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -64 | -55 | -42 | -3 | 470 |
| Other Investing Activity | -250 | -250 | 0 | 0 | 440 |
| Investing Cash Flow | $-314 | $-305 | $-42 | $-3 | $910 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,924 | 563 | 44 | N/A | 49,427 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -8,637 |
| Financing Cash Flow | $9,924 | $563 | $44 | $N/A | $40,790 |
| Exchange Rate Effect | -51 | 223 | -103 | 382 | -1,340 |
| Beginning Cash Position | 41,450 | 41,450 | 41,450 | 41,450 | 34,930 |
| End Cash Position | 21,999 | 21,052 | 26,169 | 32,981 | 41,450 |
| Net Cash Flow | $-19,451 | $-20,398 | $-15,281 | $-8,469 | $6,510 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,010 | -20,879 | -15,180 | -8,848 | -33,840 |
| Capital Expenditure | -66 | -57 | -44 | -5 | -26 |
| Free Cash Flow | -29,076 | -20,936 | -15,224 | -8,853 | -33,866 |